Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19

BACKGROUND: The risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) decreases substantially among patients who have recovered from coronavirus disease 2019 (Covid-19). However, it is unknown how long protective immunity lasts. Current guidelines recommend vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammerman, Ariel, Sergienko, Ruslan, Friger, Michael, Beckenstein, Tanya, Peretz, Alon, Netzer, Doron, Yaron, Shlomit, Arbel, Ronen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908846/
https://www.ncbi.nlm.nih.gov/pubmed/35172072
http://dx.doi.org/10.1056/NEJMoa2119497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908846/
https://www.ncbi.nlm.nih.gov/pubmed/35172072
http://dx.doi.org/10.1056/NEJMoa2119497

Ejemplares similares